Overview/Purpose
This protocol guides the user through the prescription of appropriate HRT for the patient being reviewed.
Resource type:
Product
This protocol alert is part of the PCIT toolset product
What does it do?
This protocol takes account of:
- Patients with hysterectomy
- Patients with mirena fitted
- Patients who are peri-menopausal
- Patients who are post-menopausal
and guides many options for HRT prescribing.
Why is it important?
Prescribing of HRT is often a challenge for clinicians who don't prescribe it regularly. Remembering the different formulations available can be a challenge. Equally it is important to ensure progesterone is provided for uterine protection where needed.
What does it look like?
The link for out of stock checking is shown initially:
The patient is checked to see if they need uterine protection with progesterone and the information confirmed with the user:
It it established if the patient is within 12 months of their last period:
The user is offered a choice of formulations:
When an option is chosen (in this case gel HRT), further options are shown:
The choice is then added:
and then offered for issue:
The user is guided through any other prescriptions required:
If an option to prescribe is chosen this is added:
and then offered for issue:
Users are then reminded about Genitourinary Syndrome of the Menopause and asked if they wish to prescribe, if they do they are guided through the options:
How to get it
FAQs
System Triggers
System trigger: Manual launch (via OneLauncher Prescriber)
Change management considerations
Your team need to be aware that this protocol is available to guide them through prescribing of HRT.
HP current version number: 7.0.0
Changelog
7.0.0 25/3/24
Updated to include a number of useful links for menopausal women at the outset.
Micronised progesterone offered as first line option.
Premique and Premarin removed.
Transdermal options for oestrogen offered first as doesn't increase clot risk and safer than oral oestrogen.
Options added for different dosing of oestrogen gel.
Utrogestogen dosing instructions updated to current guidelines.
Changed language to be gender-neutral.